Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a new revision of the page without changing its visible content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer shows a site release/version bump from **Revision: v3.5.2** to **Revision: v3.5.3**. Additionally, the “related topics” section content that included “Multiple myeloma” and MedlinePlus Genetics appears to have been removed.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded 'Multiple myeloma' as a topic and included a related topic link to MedlinePlus Genetics.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.5.0; removed related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and the reference 'Revision: v3.4.3'.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded related topics for Multiple myeloma and MedlinePlus Genetics on the study page to improve navigation and context.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.